
What's New
Monitoring Communication – interleukin inhibitors and possible risk of pancreatitis
Medsafe has published a new monitoring communication. The aim is to encourage reporting of any cases where pancreatitis may have been associated with an interleukin inhibitor medicine.
News and Events
Date | Type | Title |
---|---|---|
10/5/2023 | Monitoring Communication | ![]() |
10/5/2023 | Committees | Comments on agenda items for the 70th meeting of the Medicines Classification Committee |
26/4/2023 | Information Leaflet | Stopping antidepressants: be cautious and go slow |
26/4/2023 | Monitoring Communication | Review of pholcodine-containing medicines - Provide your feedback by 8 May 2023 |
12/4/2023 | Alert Communication | Topiramate use in pregnancy: further restrictions for safety |
4/4/2023 | Committees | Medicines Assessment Advisory Committee - Vacancy for an Oncologist or Specialist Clinician |